CIDP Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

Rituximab in Chronic Inflammatory Demyelinating Polyneuropathy: A Phase II Study
Condition:   Chronic Inflammatory Demyelinating Polyneuropathy Intervention:   Drug: Rituximab Sponsor:   University of Kansas Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 21, 2020 Category: Research Source Type: clinical trials

Do IgG Level Variations in CIDP and Multifocal Motor Neuropathy Patients Following Initial Intravenous Immunoglobulin Treatment Correlate With Ultimate Dosing
Condition:   Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN) Intervention:   Sponsors:   Walton Centre NHS Foundation Trust;   Grifols UK Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 22, 2020 Category: Research Source Type: clinical trials